An update in breast cancer management for elderly patients

Domenico Fusco, Elena Allocca, Emanuele Rocco Villani, Laura Franza, Alice Laudisio, Giuseppe Colloca

Research output: Contribution to journalReview article

Abstract

Breast cancer in commonly diagnosed in older women. Older women are underrepresented in clinical trials and evidence on the best treatment are insufficient. Ageing is associated with increased number of comorbidities, polypharmacy, geriatric syndromes, as well as with progressive loss of resilience to stressors, a phenomenon known as frailty. The large variety in characteristics within this population, together with the lack of evidence on the most suitable therapeutic approach and the limited data on older patients' preferences, make treatment decision-making for these patients generally difficult Frail or pre-frail older adults have a high risk of experiencing adverse effects and complications from surgery, radiotherapy and systemic therapies (either chemotherapy, biological or hormonal therapies). At present comprehensive geriatric assessment represent the best instrument to assess biological age and to assist surgeons, medical oncologists and radiotherapists in defining a personalized approach to the care of older women with breast cancer. According to guidelines we propose the use of a screening tools (such as G8) to identify those patients which are frail or pre-frail and that should undergo more comprehensive assessment as well as specific interventions. Health related quality of life and patient reported outcomes are discussed as relevant issues in the care of older women with breast cancer.

Original languageEnglish
Pages (from-to)S319-S328
JournalTranslational Cancer Research
Volume7
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Breast Neoplasms
Geriatric Assessment
Therapeutics
Frail Elderly
Polypharmacy
Patient Preference
Population Characteristics
Geriatrics
Comorbidity
Decision Making
Radiotherapy
Quality of Life
Clinical Trials
Guidelines
Drug Therapy

Keywords

  • Breast cancer
  • Elderly
  • Tailored personalized treatment

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

An update in breast cancer management for elderly patients. / Fusco, Domenico; Allocca, Elena; Villani, Emanuele Rocco; Franza, Laura; Laudisio, Alice; Colloca, Giuseppe.

In: Translational Cancer Research, Vol. 7, 01.04.2018, p. S319-S328.

Research output: Contribution to journalReview article

Fusco, D, Allocca, E, Villani, ER, Franza, L, Laudisio, A & Colloca, G 2018, 'An update in breast cancer management for elderly patients', Translational Cancer Research, vol. 7, pp. S319-S328. https://doi.org/10.21037/tcr.2018.03.21
Fusco, Domenico ; Allocca, Elena ; Villani, Emanuele Rocco ; Franza, Laura ; Laudisio, Alice ; Colloca, Giuseppe. / An update in breast cancer management for elderly patients. In: Translational Cancer Research. 2018 ; Vol. 7. pp. S319-S328.
@article{d835cd6f918144e891032cd02dce5fb5,
title = "An update in breast cancer management for elderly patients",
abstract = "Breast cancer in commonly diagnosed in older women. Older women are underrepresented in clinical trials and evidence on the best treatment are insufficient. Ageing is associated with increased number of comorbidities, polypharmacy, geriatric syndromes, as well as with progressive loss of resilience to stressors, a phenomenon known as frailty. The large variety in characteristics within this population, together with the lack of evidence on the most suitable therapeutic approach and the limited data on older patients' preferences, make treatment decision-making for these patients generally difficult Frail or pre-frail older adults have a high risk of experiencing adverse effects and complications from surgery, radiotherapy and systemic therapies (either chemotherapy, biological or hormonal therapies). At present comprehensive geriatric assessment represent the best instrument to assess biological age and to assist surgeons, medical oncologists and radiotherapists in defining a personalized approach to the care of older women with breast cancer. According to guidelines we propose the use of a screening tools (such as G8) to identify those patients which are frail or pre-frail and that should undergo more comprehensive assessment as well as specific interventions. Health related quality of life and patient reported outcomes are discussed as relevant issues in the care of older women with breast cancer.",
keywords = "Breast cancer, Elderly, Tailored personalized treatment",
author = "Domenico Fusco and Elena Allocca and Villani, {Emanuele Rocco} and Laura Franza and Alice Laudisio and Giuseppe Colloca",
year = "2018",
month = "4",
day = "1",
doi = "10.21037/tcr.2018.03.21",
language = "English",
volume = "7",
pages = "S319--S328",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - An update in breast cancer management for elderly patients

AU - Fusco, Domenico

AU - Allocca, Elena

AU - Villani, Emanuele Rocco

AU - Franza, Laura

AU - Laudisio, Alice

AU - Colloca, Giuseppe

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Breast cancer in commonly diagnosed in older women. Older women are underrepresented in clinical trials and evidence on the best treatment are insufficient. Ageing is associated with increased number of comorbidities, polypharmacy, geriatric syndromes, as well as with progressive loss of resilience to stressors, a phenomenon known as frailty. The large variety in characteristics within this population, together with the lack of evidence on the most suitable therapeutic approach and the limited data on older patients' preferences, make treatment decision-making for these patients generally difficult Frail or pre-frail older adults have a high risk of experiencing adverse effects and complications from surgery, radiotherapy and systemic therapies (either chemotherapy, biological or hormonal therapies). At present comprehensive geriatric assessment represent the best instrument to assess biological age and to assist surgeons, medical oncologists and radiotherapists in defining a personalized approach to the care of older women with breast cancer. According to guidelines we propose the use of a screening tools (such as G8) to identify those patients which are frail or pre-frail and that should undergo more comprehensive assessment as well as specific interventions. Health related quality of life and patient reported outcomes are discussed as relevant issues in the care of older women with breast cancer.

AB - Breast cancer in commonly diagnosed in older women. Older women are underrepresented in clinical trials and evidence on the best treatment are insufficient. Ageing is associated with increased number of comorbidities, polypharmacy, geriatric syndromes, as well as with progressive loss of resilience to stressors, a phenomenon known as frailty. The large variety in characteristics within this population, together with the lack of evidence on the most suitable therapeutic approach and the limited data on older patients' preferences, make treatment decision-making for these patients generally difficult Frail or pre-frail older adults have a high risk of experiencing adverse effects and complications from surgery, radiotherapy and systemic therapies (either chemotherapy, biological or hormonal therapies). At present comprehensive geriatric assessment represent the best instrument to assess biological age and to assist surgeons, medical oncologists and radiotherapists in defining a personalized approach to the care of older women with breast cancer. According to guidelines we propose the use of a screening tools (such as G8) to identify those patients which are frail or pre-frail and that should undergo more comprehensive assessment as well as specific interventions. Health related quality of life and patient reported outcomes are discussed as relevant issues in the care of older women with breast cancer.

KW - Breast cancer

KW - Elderly

KW - Tailored personalized treatment

UR - http://www.scopus.com/inward/record.url?scp=85045893636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045893636&partnerID=8YFLogxK

U2 - 10.21037/tcr.2018.03.21

DO - 10.21037/tcr.2018.03.21

M3 - Review article

AN - SCOPUS:85045893636

VL - 7

SP - S319-S328

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -